Nanotechnology In Cancer Treatment Market Report 2026

Nanotechnology In Cancer Treatment Market Overview

• Nanotechnology In Cancer Treatment market size has reached to $159.07 billion in 2025 • Expected to grow to $319.04 billion in 2030 at a compound annual growth rate (CAGR) of 14.9% • Growth Driver: Rising Demand For Targeted Therapies Drives Growth In Nanotechnology-Based Cancer Treatment Due To Their Precision In Attacking Cancer Cells • Market Trend: Breakthrough In Nanotechnology-Enabled Immunotherapy For Precision Cancer Treatment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Nanotechnology In Cancer Treatment Market?

Nanotechnology in cancer treatment involves utilizing nanoscale materials and tools to enhance cancer diagnosis, monitoring, and therapy. It allows for precise drug delivery to cancer cells, reducing harm to surrounding healthy tissues. This approach aims to boost treatment effectiveness, lower side effects, and support personalized medicine strategies. The main types of nanotechnology in cancer treatment are liposomes, dendrimers, and nanoparticles. Liposomes refer to tiny spherical vesicles made from lipid bilayers used to deliver drugs directly to targeted cells in the body. The treatment types include chemotherapy, immunotherapy, targeted therapy, combined therapy approaches, and surgery assistance and are used for various cancer types, such as breast cancer, lung cancer, prostate cancer, colorectal cancer, blood cancer, and others. These are used in several applications, including targeted drug delivery, photothermal therapy, radiation therapy enhancement, diagnostics and imaging, and gene delivery systems, and also by various end-users such as hospitals, research institutions, diagnostic laboratories, pharmaceutical companies, and contract research organizations (CROs).

What Is The Nanotechnology In Cancer Treatment Market Growth Forecast?

The nanotechnology in cancer treatment market size is expected to see rapid growth in the next few years. It will grow to $319.04 billion in 2030 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to increasing adoption of personalized cancer treatment approaches, rising investments in nanomedicine research, expansion of clinical trials using nanotechnology, growing focus on minimally invasive cancer therapies, advancements in nano-enabled diagnostics. Major trends in the forecast period include increasing development of nanoparticle-based drug delivery systems, rising adoption of targeted cancer therapies, growing use of multifunctional nanomaterials, expansion of personalized oncology treatments, enhanced focus on reducing chemotherapy side effects.

Global Nanotechnology In Cancer Treatment Market Segmentation

1) By Nanotechnology Type: Liposomes, Dendrimers, Nanoparticles 2) By Treatment Type: Chemotherapy, Immunotherapy, Targeted Therapy, Combined Therapy Approaches, Surgery Assistance 3) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, Other Cancer Types 4) By Application: Targeted Drug Delivery, Photothermal Therapy, Radiation Therapy Enhancement, Diagnostics And Imaging, Gene Delivery Systems 5) By End-User: Hospitals, Research Institutions, Diagnostics Laboratories, Pharmaceutical Companies, Contract Research Organizations (CROs) Subsegments: 1) By Liposomes: Conventional Liposomes, Stealth Liposomes, Cationic Liposomes, Immunoliposomes 2) By Dendrimers: Polyamidoamine Dendrimers, Polypropyleneimine Dendrimers, Peptide-Based Dendrimers, Carbosilane Dendrimers 3) By Nanoparticles: Gold Nanoparticles, Magnetic Nanoparticles, Polymeric Nanoparticles, Quantum Dots, Lipid Nanoparticles

What Is The Driver Of The Nanotechnology In Cancer Treatment Market?

The growing demand for targeted therapies is expected to propel the growth of nanotechnology in the cancer treatment market going forward. Targeted therapies refer to cancer treatments that specifically target molecular markers or pathways involved in tumor growth and progression. The rise in demand for targeted therapies is due to their ability to precisely attack cancer cells, reducing damage to healthy tissue and minimizing side effects. Nanotechnology in cancer treatment enhances targeted therapies by enabling precise delivery of drugs directly to cancer cells, improving effectiveness and minimizing harm to healthy tissues. For instance, in July 2023, according to the report published by the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, at the end of Q1 2023, there were 247 gene therapies in Phase II, this number rose by 5% and reached 260 by the end of Q2 2023. Therefore, the growing demand for targeted therapies is driving the growth of nanotechnology in the cancer treatment market.

Key Players In The Global Nanotechnology In Cancer Treatment Market

Major companies operating in the nanotechnology in cancer treatment market are Pfizer Inc., AstraZeneca PLC, Novartis AG, Amgen Inc., GE Healthcare Technologies Inc., Eisai Co. Ltd., Jazz Pharmaceuticals plc, Arrowhead Pharmaceuticals Inc., Nanobiotix S.A., EnGeneIC Ltd., Nanospectra Biosciences Inc., Sona Nanotech Inc., Immix Biopharma Inc., DNA Nanobots LLC, Nanovery Limited, CytImmune Sciences Inc., NanOlogy LLC, NanoApps Medical Inc., Selecta Biosciences Inc., Bind Therapeutics Inc., BlueWillow Biologics Inc., Nanobiomed Inc.

Global Nanotechnology In Cancer Treatment Market Trends and Insights

Major companies operating in the nanotechnology in cancer treatment market are focusing on developing advanced treatments such as immunotherapy nano formulation to enhance immune system targeting and minimize adverse effects in cancer patients. Immunotherapy nano formulation uses nanotechnology to deliver immune-based therapies directly to target sites, enhancing precision treatment while improving drug stability, bioavailability, and immune response activation. For instance, in December 2023, Cello Therapeutics, a US-based biotechnology company, launched CE120, a broad-spectrum therapeutic cancer nano vaccine that secured Food and Drug Administration clearance. This therapy marks the first clinical use of platelet membrane-coated nanoparticles for treating solid tumors. CE120 combines targeted drug delivery with immune system activation, aiming to destroy tumors and prevent recurrence. Its unique nanotechnology platform enhances both therapeutic precision and immune response. This milestone positions CE120 as a pioneering nanomedicine in cancer treatment.

What Are Latest Mergers And Acquisitions In The Nanotechnology In Cancer Treatment Market?

In March 2023, Sona Nanotech Inc., a Canada-based company that offers nanotechnology in cancer treatments, acquired Siva Therapeutics for $2.0 million. With this acquisition, Sona Nanotech aims to expand into cancer therapeutics by developing gold nanorod-based targeted hyperthermia treatments for solid tumors, supporting Sona’s goal of advancing nanotech-based cancer treatments. Siva Therapeutics Inc. is a US-based company that develops nanotechnology-based cancer treatments, specifically through its targeted hyperthermia therapy (THT) platform.

Regional Outlook

North America was the largest region in the nanotechnology in cancer treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Nanotechnology In Cancer Treatment Market?

The nanotechnology in cancer treatment market consists of revenues earned by entities by providing services such as hyperthermia therapy services, multi-drug co-delivery services, and immune checkpoint modulation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The nanotechnology in cancer treatment market also includes sales of magnetic nanoparticles, carbon nanotubes, polymeric nanoparticles, and quantum dots. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Nanotechnology In Cancer Treatment Market Report 2026?

The nanotechnology in cancer treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the nanotechnology in cancer treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.